Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
European Urology Open Science
|
September 22, 2021
TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-Referee
Roderick C N van den Bergh, Lieke Wever, Harm H E van Melick
European Urology Open Science
|
September 1, 2022
Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
Joris G Heetman, Lieke Wever, Leonor J Paulino Pereira, et al.
Urologic Oncology
|
November 21, 2020
Minimally invasive evaluation of the clinically negative inguinal node in penile cancer: Dynamic sentinel node biopsy
Lieke Wever, Hielke-Martijn de Vries, Henk van der Poel, et al.
BJU International
|
March 8, 2022
Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer
Lieke Wever, Hielke M de Vries, Paolo Dell'Oglio, et al.
European Urology Focus
|
December 12, 2025
Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis
Tessa van Elst, Pedro Lopez, Laurien M Buffart, et al.
World Journal of Urology
|
November 7, 2022
A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy
Joris G Heetman, Timo F W Soeterik, Lieke Wever, et al.
European Urology Oncology
|
June 9, 2023
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)
Joris G Heetman, Jules Lavalaye, Pepijn D Polm, et al.
European Urology Focus
|
December 22, 2021
Clinical Trial Protocol for PSMA-SELECT: A Dutch National Randomised Study of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as a Triage Tool for Pelvic Lymph Node Dissection in Patients Undergoing Radical Prostatectomy
Timo F W Soeterik, Lieke Wever, Lea M Dijksman, et al.
The Prostate
|
May 5, 2024
The additional value of <sup>68</sup>Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy
Joris G Heetman, Leonor J Paulino Pereira, Johannes C Kelder, et al.
BJUI Compass
|
December 12, 2025
Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysis
Lotte G Zuur, Katelijne C C de Bie, Lieke Wever, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
European Urology Open Science
|
September 22, 2021
TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-Referee
Roderick C N van den Bergh, Lieke Wever, Harm H E van Melick
European Urology Open Science
|
September 1, 2022
Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
Joris G Heetman, Lieke Wever, Leonor J Paulino Pereira, et al.
Urologic Oncology
|
November 21, 2020
Minimally invasive evaluation of the clinically negative inguinal node in penile cancer: Dynamic sentinel node biopsy
Lieke Wever, Hielke-Martijn de Vries, Henk van der Poel, et al.
BJU International
|
March 8, 2022
Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer
Lieke Wever, Hielke M de Vries, Paolo Dell'Oglio, et al.
European Urology Focus
|
December 12, 2025
Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis
Tessa van Elst, Pedro Lopez, Laurien M Buffart, et al.
World Journal of Urology
|
November 7, 2022
A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy
Joris G Heetman, Timo F W Soeterik, Lieke Wever, et al.
European Urology Oncology
|
June 9, 2023
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)
Joris G Heetman, Jules Lavalaye, Pepijn D Polm, et al.
European Urology Focus
|
December 22, 2021
Clinical Trial Protocol for PSMA-SELECT: A Dutch National Randomised Study of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as a Triage Tool for Pelvic Lymph Node Dissection in Patients Undergoing Radical Prostatectomy
Timo F W Soeterik, Lieke Wever, Lea M Dijksman, et al.
The Prostate
|
May 5, 2024
The additional value of <sup>68</sup>Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy
Joris G Heetman, Leonor J Paulino Pereira, Johannes C Kelder, et al.
BJUI Compass
|
December 12, 2025
Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysis
Lotte G Zuur, Katelijne C C de Bie, Lieke Wever, et al.
Page
of 3